Protalix BioTherapeutics, Inc. (PLX) financial statements (2021 and earlier)

Company profile

Business Address 2 SNUNIT ST
CARMIEL, 2161401
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments18385163765586
Cash and cash equivalents18385163765586
Restricted cash and investments     0 
Receivables5521 22
Inventory, net of allowances, customer advances and progress billings8985678
Inventory8985678
Prepaid expense     00
Disposal group, including discontinued operation   02  
Other current assets222222 
Other undisclosed current assets     (1)1
Total current assets:32536372866698
Noncurrent Assets
Operating lease, right-of-use asset6
Property, plant and equipment5689101114
Deferred costs     00
Defined benefit plan, assets for plan benefits2222
Other undisclosed noncurrent assets222    
Total noncurrent assets:1381010111315
TOTAL ASSETS:456172829778113
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1210976273
Accounts payable121097619 
Accrued liabilities     52
Employee-related liabilities     12
Interest and dividends payable     1 
Deferred revenue16
Debt5 654   
Disposal group, including discontinued operation    2  
Deferred revenue and credits 1179
Contract with customer, liability10
Other undisclosed current liabilities65844(7)14
Total current liabilities:40252366112627
Noncurrent Liabilities
Long-term debt and lease obligation554846247212
Long-term debt, excluding current maturities514846247212
Operating lease, liability5
Liabilities, other than long-term debt204134233942
Deferred revenue and credits27 13742
Deferred revenue17
Contract with customer, liability33
Liability, pension and other postretirement and postemployment benefits323222
Other liabilities155    
Other undisclosed noncurrent liabilities     6769
Total noncurrent liabilities:7689812675108114
Total liabilities:1161141049286134140
Stockholders' equity
Stockholders' equity attributable to parent(70)(53)(31)(10)11(56)(27)
Common stock0000000
Additional paid in capital270270266203194186184
Accumulated deficit(341)(323)(298)(213)(183)(241)(211)
Total stockholders' equity:(70)(53)(31)(10)11(56)(27)
TOTAL LIABILITIES AND EQUITY:456172829778113

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues55 19941410
Revenue, net   14 
Cost of revenue(11)(9)(15)(8)(1)(9)(5)
Cost of goods and services sold(1)(1) (0)(1)(2)(2)
Other undisclosed gross profit     21
Gross profit:44(9)41466
Operating expenses(55)(46)(44)(40)(32)(39)(42)
Other undisclosed operating income03636589
Operating loss:(11)(19)(36)(33)(24)(25)(27)
Nonoperating income (expense)(8)(7)(49)4(4)(5)(1)
Foreign currency transaction loss, before tax     (1) 
Other nonoperating expense(8)(7)(10)(10)(4)(5) 
Interest and debt expense(3)(3)(2)(1)(4)(4)(1)
Loss from continuing operations:(21)(29)(88)(30)(31)(33)(29)
Income (loss) from discontinued operations   (0)45  
Net income (loss):(21)(29)(88)(30)15(33)(29)
Other undisclosed net income attributable to parent33214341
Net income (loss) available to common stockholders, diluted:(18)(26)(85)(29)58(30)(28)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(21)(29)(88)(30)15(33)(29)
Comprehensive income (loss), net of tax, attributable to parent:(21)(29)(88)(30)15(33)(29)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: